Article
Year-End 2022 Review of Key Pharma R&D Events
IQVIA Pipeline Link
Feb 23, 2023

Despite rising energy and raw material costs in 2022 due to inflationary pressures and the increase in demand as the global economy emerged from the COVID-19 pandemic, the pharmaceutical industry has achieved some notable successes in the advancement of milestone therapies for chronic, progressive and debilitating conditions affecting millions of patients worldwide. This review provides an insight into key selected significant therapeutic developments and product approvals in 2022.

Please fill in your details on the left to download the article.

Related solutions

Contact Us